Literature DB >> 17202459

Molecular signatures of lung cancer--toward personalized therapy.

Roy S Herbst, Scott M Lippman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17202459     DOI： 10.1056/NEJMe068218

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

Review 1.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

2.  Identification of RET gene fusion by exon array analyses in "pan-negative" lung cancer from never smokers.

Authors:  Fei Li; Yan Feng; Rong Fang; Zhaoyuan Fang; Jufeng Xia; Xiangkun Han; Xin-Yuan Liu; Haiquan Chen; Hongyan Liu; Hongbin Ji
Journal:  Cell Res       Date:  2012-02-21       Impact factor: 25.617

3.  Paying for personalized care: cancer biomarkers and comparative effectiveness.

Authors:  Rahber Thariani; David L Veenstra; Josh J Carlson; Louis P Garrison; Scott Ramsey
Journal:  Mol Oncol       Date:  2012-03-06       Impact factor: 6.603

4.  Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

Authors:  Daniel D Karp; Sandra J Lee; Steven M Keller; Gail Shaw Wright; Seena Aisner; Steven Alan Belinsky; David H Johnson; Michael R Johnston; Gary Goodman; Gerald Clamon; Gordon Okawara; Randolph Marks; Eric Frechette; Worta McCaskill-Stevens; Scott M Lippman; John Ruckdeschel; Fadlo R Khuri
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

Review 5.  EGFR/HER-targeted therapeutics in ovarian cancer.

Authors:  Jason A Wilken; Tayf Badri; Sarah Cross; Rhoda Raji; Alessandro D Santin; Peter Schwartz; Adam J Branscum; Andre T Baron; Adam I Sakhitab; Nita J Maihle
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

Review 6.  From tissue to molecular phenotyping: pre-analytical requirements heidelberg experience.

Authors:  Thomas R Muley; Felix Jf Herth; Philipp A Schnabel; Hendrik Dienemann; Michael Meister
Journal:  Transl Lung Cancer Res       Date:  2012-06

Review 7.  Molecular targets of phytochemicals for cancer prevention.

Authors:  Ki Won Lee; Ann M Bode; Zigang Dong
Journal:  Nat Rev Cancer       Date:  2011-02-10       Impact factor: 60.716

8.  Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma.

Authors:  Fei Li; Zhaoyuan Fang; Jian Zhang; Chen Li; Hongyan Liu; Jufeng Xia; Hongwen Zhu; Chenchen Guo; Zhen Qin; Fuming Li; Xiangkun Han; Yuetong Wang; Yan Feng; Ye Wang; Wenjing Zhang; Zuoyun Wang; Yujuan Jin; Yihua Sun; Wenyi Wei; Rong Zeng; Haiquan Chen; Hongbin Ji
Journal:  Cell Res       Date:  2016-09-27       Impact factor: 25.617

Review 9.  Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?

Authors:  Alfredo Fucito; Chiara Lucchetti; Antonio Giordano; Gaetano Romano
Journal:  Int J Biochem Cell Biol       Date:  2007-10-23       Impact factor: 5.085

10.  Molecular recognition of small-cell lung cancer cells using aptamers.

Authors:  Hui William Chen; Colin D Medley; Kwame Sefah; Dihua Shangguan; Zhiwen Tang; Ling Meng; Josh E Smith; Weihong Tan
Journal:  ChemMedChem       Date:  2008-06       Impact factor: 3.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.